{"id":2653,"date":"2021-01-20T08:47:52","date_gmt":"2021-01-19T23:47:52","guid":{"rendered":"http:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/?page_id=2653"},"modified":"2024-12-02T16:45:21","modified_gmt":"2024-12-02T07:45:21","slug":"2016-2","status":"publish","type":"page","link":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/2016-2\/","title":{"rendered":"2016"},"content":{"rendered":"

2016 (\u8ad6\u6587)<\/h2>\n
    \n
  1. Iikuni S, Ono M, Watanabe H, Yoshimura M, Ishibashi-Ueda H, Ihara M, Saji H.<\/span><\/span>
    \nNovel Bivalent 99m<\/sup>Tc-Complex with N-Methyl-Substituted Hydroxamamide as Probe for Imaging of Cerebral Amyloid Angiopathy<\/span><\/span>
    \nPLoS ONE<\/span><\/em>, <\/span>11(9) e0163969 (2016)<\/li>\n
  2. Ono M, Watanabe H, Kitada A, Matsumura K, Ihara M, Saji H.<\/span><\/span>
    \nHighly Selective Tau-SPECT Imaging Probes for Detection of Neurofibrillary Tangles in Alzheimer\u2019s Disease<\/span><\/span>
    \nSci. Rep.<\/em>\u00a06 34197 (2016)<\/span>
    \n<\/span><\/li>\n
  3. Kimura H, Yagi Y, Arimitsu K, Maeda K, Ikejiri K, Takano J, Kusuhara H, Kagawa S, Ono M, Sugiyama Y, Saji H.<\/span><\/span>
    \nRadiosynthesis of Novel Pitavastatin Derivative ([18<\/sup>F]PTV-F1) as a Tracer for hepatic OATP Using a One-Pot Synthetic Procedure<\/span><\/span>
    \nJ. Labelled Comp. Radiopharm.<\/em>\u00a059(13) 565-575 (2016)<\/span><\/li>\n
  4. Kanazaki K, Sano K, Makino A, Homma T, Ono M, Saji H.<\/span>
    \nPolyoxazoline multivalently conjugated with indocyanine green for sensitive in vivo photoacoustic imaging of tumors<\/span><\/span>
    \n Sci. Rep<\/em>.\u00a0<\/span>6 33798 (2016)<\/li>\n
  5. Kimura H, Tomatsu K, Saiki H, Arimitsu K, Ono M, Kawashima H, Iwata R, Nakanishi H, Ozeki E, Kuge Y, Saji H.<\/span>
    \nContinuous-flow synthesis of N<\/em>-succinimidyl 4-[18<\/sup>F]fluorobenzoate using a single microfluidic chip<\/span>
    \nPLoS ONE\u00a0<\/em><\/span>11(7) e0159303 (2016)<\/span><\/span><\/li>\n
  6. Harada N, Kimura H, Onoe S, Watanabe H, Matsuoka D, Arimitsu K, Ono M, Saji H.<\/span>
    \nSynthesis and Biological Evaluation of Novel 18<\/sup>F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for Positron Emission Tomography of Prostate Cancer<\/span>
    \nJ. Nucl. Med.<\/em><\/span>\u00a0<\/em>57(12) 1978-1984 (2016)<\/span><\/span><\/li>\n
  7. Ding N, Sano K, Kanazaki K, Ohashi M, Deguchi J, Kanada Y, Ono M, Saji H.<\/span>
    \nIn vivo HER2-Targeted Magnetic Resonance Tumor Imaging Using Iron Oxide Nanoparticles Conjugated with Anti-HER2 Fragment Antibody<\/span>
    \nMol. Imaging Biol.\u00a0<\/em><\/span><\/span>18(6) 870-876 (2016)<\/li>\n
  8. Yoshimura M, Ono M, Watanabe H, Kimura H, Saji H.<\/span>
    \nDevelopment of 99m<\/sup>Tc-labeled Pyridyl Benzofuran Derivatives to Detect Pancreatic Amylin in Islet Amyloid Model Mice<\/span>
    \nBioconjug. Chem. <\/em>27(6) 1532-1539 (2016)<\/span><\/span><\/li>\n
  9. Watanabe H, Kawasaki A, Sano K, Ono M, Saji H.<\/span>
    \nSynthesis and evaluation of copper-64 labeled benzofuran derivatives targeting \u03b2-amyloid aggregates<\/span>
    \nBioorg. Med. Chem. <\/em>24(16) 3618-3623 (2016)<\/span>
    \n<\/span><\/span><\/li>\n
  10. Kurihara K, Ueda M, Hara I, Hara E, Sano K, Makino A, Ozeki E, Yamamoto F, Saji H, Togashi K, Kimura S.<\/span>
    \nInflammation-induced synergetic enhancement of nanoparticle treatments with DOXIL\u00ae and 90<\/sup>Y-Lactosome for orthotopic mammary tumor<\/span>
    \nJ. Nanopart. Res. <\/em>18 137 (2016)<\/span>
    \n<\/span><\/span><\/li>\n
  11. Nakamoto Y, Ishimori T, Sano K, Temma T, Ueda M, Saji H, Togashi K.<\/span>
    \nClinical efficacy of dual-phase scanning using 68<\/sup>Ga-DOTATOC-PET\/CT in the detection of neuroendocrine tumours<\/span>
    \nClin. Radiol.\u00a0<\/em><\/span>71 1069.e1-1069.e5 (2016)<\/span><\/li>\n
  12. Iikuni S, Ono M, Watanabe H, Matsumura K, Yoshimura M, Kimura H, Ishibashi-Ueda H, Okamoto Y, Ihara M, Saji H.
    \n<\/span>Imaging of Cerebral Amyloid Angiopathy with Bivalent 99m<\/sup>Tc-Hydroxamamide Complexes<\/span>
    \n Sci. Rep.<\/span>\u00a0<\/em>6 25990 (2016)<\/span><\/li>\n
  13. Ono M, Doi Y, Watanabe H, Ihara M, Ozaki A, Saji H.
    \n<\/span>Structure-Activity Relationships of Radioiodinated Diphenyl Derivatives with Different Conjugated Double Bonds as Ligands for \u03b1-Synuclein Aggregates<\/span>
    \n RSC Adv.<\/span>\u00a0<\/em>6(50) 44305-44312 (2016)<\/span><\/li>\n
  14. Ono M, Kitada A, Watanabe H, Miyazaki A, Kimura H, Saji H.
    \n<\/span>Synthesis and Preliminary Characterization of Radioiodinated Benzofuran-3-yl-(indol-3-yl)maleimide Derivatives as Potential SPECT Imaging Probes for the Detection of Glycogen Synthase Kinase-3\u03b2 (GSK-3\u03b2) in the Brain<\/span>
    \n J. Labelled Comp. Radiopharm.<\/span>\u00a0<\/em>59(8) 317-321 (2016)<\/span><\/li>\n
  15. Kimura H, Sampei S, Matsuoka D, Harada N, Watanabe H, Arimitsu K, Ono M, Saj H.
    \n<\/span>Development of 99m<\/sup>Tc-labeled Asymmetric Urea Derivatives that Target Prostate-Specific Membrane Antigen for Single-photon Emission Computed Tomography Imaging<\/span>
    \n Bioorg. Med. Chem.<\/span>\u00a0<\/em>24(10) 2251-2256 (2016)<\/span><\/li>\n
  16. Matsuura Y, Ueda M, Higaki Y, Watanabe K, Habara S, Kamino S, Saji H, Enomoto S.
    \n<\/span>Noninvasive evaluation of nicotinic acetylcholine receptor availability in mouse brain using single-photon emission computed tomography with [123<\/sup>I]5IA<\/span>
    \n Nucl. Med. Biol.<\/span>\u00a0<\/em>43(6) 372-378 (2016)<\/span><\/li>\n
  17. Kanazaki K, Sano K, Makino A, Yamauchi F, Takahashi A, Homma T, Ono M, Saji H.
    \n<\/span>Feasibility of poly(ethylene glycol) derivatives as diagnostic drug carriers for tumor imaging<\/span>
    \n J. Control. Release<\/span>\u00a0<\/em>226\u00a0115-123 (2016)<\/span><\/li>\n
  18. Abe T, Naruse M, Young W. F., Kobashi N, Doi Y, Izawa A, Akama K, Okumura Y, Ikenaga M, Kimura H, Saji H, Mukai K, Matsumoto H.
    \n<\/span>A novel CYP11B2-specific imaging agent for detection of unilateral subtypes of primary aldosteronism<\/span>
    \n J. Clin. Endocrinol. Metab. <\/em>101(3) 1008-1015 (2016)<\/span><\/li>\n
  19. Makino A, Arai T, Hirata M, Ono M, Ohmomo Y, Saji H.
    \n<\/span>Development of novel PET probes targeting phosphatidylinositol 3-kinase (PI3K) in tumors<\/span>
    \n Nucl. Med. Biol.<\/em>\u00a043(1) 101-107 (2016)<\/span><\/li>\n<\/ol>\n
    \n

    2016 (\u5b66\u4f1a\u767a\u8868)<\/h2>\n
      \n
    1. Kohei Sano, Yuko Kanada, Kengo Kanazaki, Ning Ding, Masahiro Ono, Hideo Saji.
      \n<\/span>Brachytherapy using 90<\/sup>Y-labeled thermo-responsive polymers thatself-aggregate in tumor tissues<\/span>
      \n<\/span>Society of Nuclear Medicine and Molecular Imaging 2016 Annual Meeting<\/span>\uff08San Diego, USA\uff09<\/span>June 11-15, 2016<\/span><\/span><\/li>\n
    2. Hiroyuki Watanabe, Masahiro Ono, Ayane Kitada, Hideo Saji.
      \n<\/span>Novel Tau-SPECT Tracers Based on Benzoimidazopyridine for Imaging Tau Aggregates in Alzheimer\u2019s Disease.<\/span>
      \n<\/span>Society of Nuclear Medicine and Molecular Imaging 2016 Annual Meeting<\/span>\uff08San Diego, USA\uff09June 11-15, 2016<\/span><\/span><\/li>\n
    3. \u5ddd\u5d0e \u6893, \u6e21\u908a \u88d5\u4e4b, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce
      \n<\/span><\/span>\u8133\u03b2\u30bb\u30af\u30ec\u30bf\u30fc\u30bc\u306e\u9175\u7d20\u6d3b\u6027\u306e\u6838\u533b\u5b66\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f\u65b0\u898fSPECT\u7528\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a
      \n<\/span><\/span>\u7b2c56\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff08\u540d\u53e4\u5c4b\uff092016\u5e7411\u67083\u65e5\u301c5\u65e5<\/span><\/span><\/li>\n
    4. \u6c60\u7551 \u88d5\u8cb4, \u5c0f\u91ce \u6b63\u535a, \u5409\u6751 \u512a\u5fd7, \u4e01 \u5be7, \u6e21\u908a \u88d5\u4e4b, \u4f50\u91ce \u7d18\u5e73, \u4f50\u6cbb \u82f1\u90ce
      \n<\/span><\/span>RI\/ \u86cd\u5149\u30c7\u30e5\u30a2\u30eb\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d7\u30ed\u30fc\u30d6\u958b\u767a\u306b\u5411\u3051\u305f\u653e\u5c04\u6027\u30e8\u30a6\u7d20\u6a19\u8b58BODIPY \u306e\u6709\u7528\u6027\u8a55\u4fa1
      \n<\/span><\/span>\u7b2c56\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff08\u540d\u53e4\u5c4b\uff092016\u5e7411\u67083\u65e5\u301c5\u65e5<\/span><\/span><\/li>\n
    5. \u6e21\u908a \u88d5\u4e4b, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce.
      \n\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u8133\u306e\u03b2\u30a2\u30df\u30ed\u30a4\u30c9\u3001\u30bf\u30a6\u306e\u751f\u4f53\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306b\u8cc7\u3059\u308b\u653e\u5c04\u6027\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a
      \n<\/span><\/span>\u7b2c66\u56de\u65e5\u672c\u85ac\u5b66\u4f1a\u8fd1\u757f\u652f\u90e8\u7dcf\u4f1a\u30fb\u5927\u4f1a\uff08\u5927\u962a\uff092016\u5e7410\u670815\u65e5<\/span><\/span><\/li>\n
    6. \u5317\u7530 \u5f69\u97f3, \u5c0f\u91ce \u6b63\u535a, \u6e21\u908a \u88d5\u4e4b, \u4f50\u6cbb \u82f1\u90ce<\/span><\/span>
      \n\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u8133\u5185\u30bf\u30a6\u306eSPECT\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f\u65b0\u898f\u653e\u5c04\u6027\u30e8\u30a6\u7d20\u6a19\u8b58\u30d9\u30f3\u30be\u30a4\u30df\u30c0\u30be\u30d4\u30ea\u30b8\u30f3\u8a98\u5c0e\u4f53\u306e\u958b\u767a
      \n<\/span><\/span>\u7b2c16\u56de\u653e\u5c04\u6027\u533b\u85ac\u54c1\u30fb\u753b\u50cf\u8a3a\u65ad\u85ac\u7814\u7a76\u4f1a\uff08\u4eac\u90fd) 2016\u5e7410\u67081\u65e5<\/span><\/span><\/li>\n
    7. \u6709\u5409 \u6cf0\u4eae, \u6e21\u908a \u88d5\u4e4b, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce
      \n<\/span>\u03b1\u30b7\u30cc\u30af\u30ec\u30a4\u30f3\u306e\u6838\u533b\u5b66\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f\u30d9\u30f3\u30be\u30a4\u30df\u30c0\u30be\u30fc\u30eb\u8a98\u5c0e\u4f53\u306e\u5408\u6210\u3068\u8a55\u4fa1
      \n<\/span>\u7b2c14\u56de\u6b21\u4e16\u4ee3\u3092\u62c5\u3046\u82e5\u624b\u306e\u305f\u3081\u306e\u30d5\u30a3\u30b8\u30ab\u30eb\u30fb\u30d5\u30a1\u30fc\u30de\u30d5\u30a9\u30fc\u30e9\u30e0<\/span>\uff08\u5927\u962a\uff092016\u5e748\u670827\u65e5, 28\u65e5<\/span><\/span><\/li>\n
    8. \u4f50\u91ce \u7d18\u5e73, \u91d1\u7530 \u4f91\u5b50, \u91d1\u5d0e \u5065\u543e, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce<\/span>
      \n\u71b1\u5fdc\u7b54\u51dd\u96c6\u6027\u30dd\u30ea\u30aa\u30ad\u30b5\u30be\u30ea\u30f3\u3092\u57fa\u76e4\u3068\u3059\u308b\u65b0\u898f\u5c0f\u7dda\u6e90\u7642\u6cd5\u7528\u85ac\u5264\u306e\u958b\u767a\u7814\u7a76<\/span>
      \n\u7b2c32\u56de\u65e5\u672cDDS\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a<\/span>\uff08\u9759\u5ca1\uff092016\u5e746\u670830\u65e5, \uff17\u67081\u65e5<\/span><\/span><\/li>\n
    9. \u677e\u5ca1 \u5927\u822a, \u6728\u6751 \u5bdb\u4e4b, \u539f\u7530 \u76f4\u5f25, \u4e09\u5e73 \u5d07\u592a\u90ce, \u6e21\u908a \u88d5\u4e4b, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce<\/span>
      \nProstate Specific Membrane Antigen\u3092\u6a19\u7684\u3068\u3057\u305f\u524d\u7acb\u817a\u304c\u3093\u6838\u533b\u5b66\u8a3a\u65ad\u7528\u653e\u5c04\u6027\u91d1\u5c5e\u6838\u7a2e99m<\/sup>Tc\u6a19\u8b58\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a<\/span>
      \n\u7b2c26\u56de\u91d1\u5c5e\u306e\u95a2\u4e0e\u3059\u308b\u751f\u4f53\u95a2\u9023\u53cd\u5fdc\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff08\u672d\u5e4c\uff092016\u5e746\u670817\u65e5, 18\u65e5<\/span><\/span><\/li>\n
    10. \u677e\u5ca1 \u5927\u822a, \u6728\u6751 \u5bdb\u4e4b, \u6e21\u908a \u88d5\u4e4b, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce
      \n<\/span>\u85ac\u5264\u6027\u814e\u969c\u5bb3\u306e\u6838\u533b\u5b66\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306e\u6a19\u7684\u3068\u3057\u3066\u306e prostate-specific membrane antigen \u306e\u53ef\u80fd\u6027<\/span>
      \n\u7b2c11\u56de\u65e5\u672c\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a \uff08\u795e\u6238\uff092016\u5e745\u670828\u65e5, 29\u65e5<\/span><\/span><\/li>\n
    11. \u4f50\u91ce \u7d18\u5e73, \u91d1\u5d0e \u5065\u543e, \u7267\u91ce \u9855, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce
      \n<\/span>\u816b\u760d\u306e\u9ad8\u611f\u5ea6\u5149\u97f3\u97ff\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f\u30a4\u30f3\u30c9\u30b7\u30a2\u30cb\u30f3\u30b0\u30ea\u30fc\u30f3\u591a\u70b9\u7d50\u5408\u30dd\u30ea\u30aa\u30ad\u30b5\u30be\u30ea\u30f3\u306e\u958b\u767a\u7814\u7a76<\/span>
      \n\u7b2c11\u56de\u65e5\u672c\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a \uff08\u795e\u6238\uff092016\u5e745\u670828\u65e5, 29\u65e5<\/span><\/span><\/li>\n
    12. \u6e21\u908a \u88d5\u4e4b, \u5ddd\u5d0e \u6893, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce<\/span>
      \n\u03b2\u30bb\u30af\u30ec\u30bf\u30fc\u30bc\u306e\u9175\u7d20\u6d3b\u6027\u3092\u6a19\u7684\u3068\u3057\u305f\u65b0\u898f\u653e\u5c04\u6027\u30e8\u30a6\u7d20\u6a19\u8b58\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a<\/span>
      \n\u7b2c11\u56de\u65e5\u672c\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a \uff08\u795e\u6238\uff092016\u5e745\u670828\u65e5, 29\u65e5<\/span><\/span><\/li>\n
    13. \u677e\u5ca1 \u5927\u822a, \u6728\u6751 \u5bdb\u4e4b, \u6e21\u908a \u88d5\u4e4b, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce
      \n<\/span>\u6838\u533b\u5b66\u7684\u624b\u6cd5\u3092\u7528\u3044\u305f\u85ac\u5264\u6027\u814e\u969c\u5bb3\u306e\u8a55\u4fa1\u6cd5\u306e\u958b\u767a<\/span>
      \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c136\u5e74\u4f1a \uff08\u6a2a\u6d5c) 2016\u5e743\u670827\u65e5\u301c29\u65e5<\/span><\/span><\/li>\n
    14. \u98ef\u570b \u614e\u5e73, \u5c0f\u91ce \u6b63\u535a, \u6e21\u908a \u88d5\u4e4b, \u5317\u7530 \u5f69\u97f3, \u677e\u5409 \u5eb7\u5fd7, \u4f50\u6cbb \u82f1\u90ce
      \n<\/span>\u30a2\u30eb\u30c4\u30cf\u30a4\u30de\u30fc\u75c5\u8133\u5185\u30bf\u30a6\u306ePET\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u76ee\u7684\u3068\u3057\u305f\u65b0\u898f18<\/sup>F\u6a19\u8b58\u30d9\u30f3\u30be\u30a4\u30df\u30c0\u30be\u30d4\u30ea\u30b8\u30f3\u8a98\u5c0e\u4f53\u306e\u958b\u767a<\/span>
      \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c136\u5e74\u4f1a \uff08\u6a2a\u6d5c)\u00a02016\u5e743\u670827\u65e5\u301c29\u65e5<\/span><\/span><\/li>\n
    15. \u91d1\u7530 \u4f91\u5b50, \u4f50\u91ce \u7d18\u5e73, \u91d1\u5d0e \u5065\u543e, \u4e01 \u5be7, \u5927\u6a4b \u611b\u7f8e, \u51fa\u53e3 \u8ac4, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce
      \n<\/span>\u71b1\u5fdc\u7b54\u51dd\u96c6\u6027\u30dd\u30ea\u30de\u30fc\u3092\u57fa\u76e4\u3068\u3059\u308b\u5c0f\u7dda\u6e90\u7642\u6cd5\u7528\u85ac\u5264\u306e\u958b\u767a<\/span>
      \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c136\u5e74\u4f1a \uff08\u6a2a\u6d5c)\u00a02016\u5e743\u670827\u65e5\u301c29\u65e5<\/span><\/span><\/li>\n
    16. \u91d1\u5d0e \u5065\u543e, \u4f50\u91ce \u7d18\u5e73, \u7267\u91ce \u9855, \u672c\u9593 \u52d9, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce
      \n<\/span>\u9ad8\u611f\u5ea6\u306a\u5149\u97f3\u97ff\u816b\u760d\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u3092\u53ef\u80fd\u3068\u3059\u308b\u30a4\u30f3\u30c9\u30b7\u30a2\u30cb\u30f3\u30b0\u30ea\u30fc\u30f3\u591a\u70b9\u7d50\u5408\u30dd\u30ea\u30aa\u30ad\u30b5\u30be\u30ea\u30f3\u306e\u958b\u767a<\/span>
      \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c136\u5e74\u4f1a \uff08\u6a2a\u6d5c)\u00a02016\u5e743\u670827\u65e5\u301c29\u65e5<\/span><\/span><\/li>\n
    17. \u571f\u4e95 \u96c4\u8cb4, \u5c0f\u91ce \u6b63\u535a, \u5409\u6751 \u512a\u5fd7, \u98ef\u570b \u614e\u5e73, \u6e21\u908a \u88d5\u4e4b, \u4f50\u6cbb \u82f1\u90ce<\/span>
      \n\u03b1\u30b7\u30cc\u30af\u30ec\u30a4\u30f3\u9078\u629e\u7684\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30d7\u30ed\u30fc\u30d6\u306e\u958b\u767a\u3092\u76ee\u7684\u3068\u3057\u305f\u65b0\u898f\u30aa\u30ad\u30b7\u30a4\u30f3\u30c9\u30fc\u30eb\u8a98\u5c0e\u4f53\u306e\u5408\u6210\u3068\u8a55\u4fa1<\/span>
      \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c136\u5e74\u4f1a \uff08\u6a2a\u6d5c)\u00a02016\u5e743\u670827\u65e5\u301c29\u65e5<\/span><\/span><\/li>\n
    18. \u6c60\u7551 \u88d5\u8cb4, \u5c0f\u91ce \u6b63\u535a, \u5409\u6751 \u512a\u5fd7, \u4e01 \u5be7, \u6e21\u908a \u88d5\u4e4b, \u4f50\u91ce \u7d18\u5e73, \u4f50\u6cbb \u82f1\u90ce<\/span>
      \n\u653e\u5c04\u6027\u30e8\u30a6\u7d20\u6a19\u8b58BODIPY\u3092\u7528\u3044\u305f\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u65b0\u898fRI\/\u86cd\u5149\u30c7\u30e5\u30a2\u30eb\u30e9\u30d9\u30eb\u6cd5\u306e\u958b\u767a<\/span>
      \n\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c136\u5e74\u4f1a \uff08\u6a2a\u6d5c)\u00a02016\u5e743\u670827\u65e5\u301c29\u65e5<\/span><\/span><\/li>\n
    19. \u4f50\u91ce \u7d18\u5e73, \u5927\u6a4b \u611b\u7f8e, \u91d1\u5d0e \u5065\u543e, \u7267\u91ce \u9855, \u4e01 \u5be7, \u51fa\u53e3 \u8ac4, \u91d1\u7530 \u4f91\u5b50, \u5c0f\u91ce \u6b63\u535a, \u4f50\u6cbb \u82f1\u90ce<\/span>
      \n\u5149\u97f3\u97ff\u816b\u760d\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306e\u305f\u3081\u306e\u30a4\u30f3\u30c9\u30b7\u30a2\u30cb\u30f3\u30b0\u30ea\u30fc\u30f3\u7d50\u5408\u30dd\u30ea\u30b5\u30eb\u30b3\u30b7\u30f3\u306e\u958b\u767a<\/span>
      \n<\/span>\u65e5\u672c\u85ac\u5b66\u4f1a \u7b2c136\u5e74\u4f1a \uff08\u6a2a\u6d5c)\u00a02016\u5e743\u670827\u65e5\u301c29\u65e5<\/span><\/span><\/li>\n<\/ol>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

      2016 (\u8ad6\u6587) Iikuni S, Ono M, Watanabe H, Yoshimura M, Ishibashi-Ueda H, Ihara M, Saji H. Novel Bivalent 99mTc-Co […]<\/p>\n","protected":false},"author":14,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-2653","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/2653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/comments?post=2653"}],"version-history":[{"count":3,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/2653\/revisions"}],"predecessor-version":[{"id":3212,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/pages\/2653\/revisions\/3212"}],"wp:attachment":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/media?parent=2653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}